Santhera Pharmaceuticals Holding AG (XSWX:SANN) Other Income (Expense) : CHF1.94 Mil (TTM As of Jun. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Santhera Pharmaceuticals Holding AG Other Income (Expense)?

Santhera Pharmaceuticals Holding AG's other income expense for the Santhera Pharmaceuticals Holding AG's pretax income for the six months ended in Jun. 2023 was CHF5.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jun. 2023 was CHF1.94 Mil.

Santhera Pharmaceuticals Holding AG Other Income (Expense) Historical Data

The historical data trend for Santhera Pharmaceuticals Holding AG's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santhera Pharmaceuticals Holding AG Other Income (Expense) Chart

Santhera Pharmaceuticals Holding AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Income (Expense)

Get a 7-Day Free Trial

2.39

-1.88

0.76

22.03

1.70

Santhera Pharmaceuticals Holding AG Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Other Income (Expense)	Get a 7-Day Free Trial															13.74	8.30	4.76	-3.06	5.00

Santhera Pharmaceuticals Holding AG Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF1.94 Mil.

Santhera Pharmaceuticals Holding AG (XSWX:SANN) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Santhera Pharmaceuticals Holding AG (XSWX:SANN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Santhera Pharmaceuticals Holding AG (XSWX:SANN) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

SPHDF:USA SANNz:UK

Address

Hohenrainstrasse 24, Pratteln, CHE, 4133

Website

https://www.santhera.com

Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area that includes many orphan and niche indications with high unmet medical needs. It has one operating segment, namely the development and commercialization of products for the treatment of neuro-ophthalmological, pulmonary, and neuromuscular diseases. The company derives most of its revenue from the European Union.

Santhera Pharmaceuticals Holding AG (XSWX:SANN) Headlines

No Headlines